Jalili, Ahmad <br/><br/>
Dual suppression of the cyclin-dependent kinase inhibitors CDKN2C and CDKN1A in human melanoma.  [electronic resource] 

 -  Journal of the National Cancer Institute  Nov 2012 
 - 1673-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1460-2105 
<br/><br/><label>Standard No.: </label>10.1093/jnci/djs373  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Aspartic Acid<br/>Benzamides--pharmacology<br/>Blotting, Western<br/>Cell Line, Tumor<br/>Cyclin-Dependent Kinase Inhibitor p18--antagonists & inhibitors<br/>Cyclin-Dependent Kinase Inhibitor p21--antagonists & inhibitors<br/>Flow Cytometry<br/>Gene Expression Regulation, Neoplastic<br/>Genes, ras<br/>Glutamic Acid<br/>Glycine<br/>Humans<br/>MAP Kinase Signaling System--drug effects<br/>Melanocytes--metabolism<br/>Melanoma--drug therapy<br/>Mice<br/>Mice, Nude<br/>Mitogen-Activated Protein Kinases--metabolism<br/>Protein Kinase Inhibitors--pharmacology<br/>Proto-Oncogene Proteins B-raf--antagonists & inhibitors<br/>Proto-Oncogene Proteins c-jun--metabolism<br/>RNA, Small Interfering<br/>Transcription Factor AP-1--metabolism<br/>Transfection<br/>Transplantation, Heterologous<br/>Valine<br/>Viral Vaccines--pharmacology